The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts
暂无分享,去创建一个
Ming Yi | Amir Jazaeri | Robert Stephens | Bih-Rong Wei | John Niederhuber | R. M. Simpson | R. Stephens | A. Jazaeri | M. Yi | J. Niederhuber | Xiang Yu | J. Risinger | O. Aprelikova | Olga Aprelikova | R Mark Simpson | John I Risinger | Xiang Yu | John Palla | Simone John | Simone John | J. Palla | B. Wei
[1] W. Frankel,et al. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles , 2004, Oncogene.
[2] L. Coussens,et al. Tumor stroma and regulation of cancer development. , 2006, Annual review of pathology.
[3] S. Srikantan,et al. Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype , 2008, Oncogene.
[4] C. Burge,et al. The microRNAs of Caenorhabditis elegans. , 2003, Genes & development.
[5] Rameen Beroukhim,et al. Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.
[6] S. Hayward,et al. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. , 2001, Cancer research.
[7] B. Xiao,et al. Differential expression of microRNA species in human gastric cancer versus non‐tumorous tissues , 2009, Journal of gastroenterology and hepatology.
[8] C. Paweletz,et al. Isolation and Characterization of SATB2, a Novel AT-rich DNA Binding Protein Expressed in Development- and Cell-Specific Manner in the Rat Brain , 2006, Neurochemical Research.
[9] I. Fariñas,et al. SATB2 Is a Multifunctional Determinant of Craniofacial Patterning and Osteoblast Differentiation , 2006, Cell.
[10] R. Stephens,et al. SLEPR: A Sample-Level Enrichment-Based Pathway Ranking Method — Seeking Biological Themes through Pathway-Level Consistency , 2008, PloS one.
[11] J. Myklebust,et al. Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer , 2007, International journal of cancer.
[12] K. Mimori,et al. Over- and under-expressed microRNAs in human colorectal cancer. , 2009, International journal of oncology.
[13] Robert A. Weinberg,et al. A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .
[14] Satoshi Matsumoto,et al. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas , 2002, Nature Genetics.
[15] H. Moses,et al. Stromal fibroblasts in cancer initiation and progression , 2004, Nature.
[16] Kylie L. Gorringe,et al. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas , 2008, Nature Genetics.
[17] X. Agirre,et al. Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues , 2006, Molecular Cancer.
[18] Aristotelis Tsirigos,et al. The autophagic tumor stroma model of cancer , 2010, Cell cycle.
[19] J. Zavadil,et al. Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma* , 2010, The Journal of Biological Chemistry.
[20] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[21] Kornelia Polyak,et al. Breast cancer: origins and evolution. , 2007, The Journal of clinical investigation.
[22] Mina J Bissell,et al. The organizing principle: microenvironmental influences in the normal and malignant breast. , 2002, Differentiation; research in biological diversity.
[23] Kornelia Polyak,et al. The role of the microenvironment in mammary gland development and cancer. , 2010, Cold Spring Harbor perspectives in biology.
[24] W. Filipowicz,et al. Relief of microRNA-Mediated Translational Repression in Human Cells Subjected to Stress , 2006, Cell.
[25] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[26] William Ignace Wei,et al. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.
[27] J. Russo,et al. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis , 2008, Nature.
[28] D. Bonthron,et al. Identification of SATB2 as the cleft palate gene on 2q32-q33. , 2003, Human molecular genetics.
[29] Z. Werb,et al. Matrix Metalloproteinase Stromelysin-1 Triggers a Cascade of Molecular Alterations That Leads to Stable Epithelial-to-Mesenchymal Conversion and a Premalignant Phenotype in Mammary Epithelial Cells , 1997, The Journal of cell biology.
[30] V. Tarabykin,et al. SATB2 interacts with chromatin‐remodeling molecules in differentiating cortical neurons , 2008, The European journal of neuroscience.
[31] Metin N. Gurcan,et al. Pten in Stromal Fibroblasts Suppresses Mammary Epithelial Tumors , 2009, Nature.
[32] Qiong Shao,et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.
[33] Robert A. Weinberg,et al. Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type , 2006, Cell cycle.
[34] Zongguang Zhou,et al. Clinicopathological Significance of microRNA-31, -143 and -145 Expression in Colorectal Cancer , 2009, Disease markers.
[35] Å. Borg,et al. MiRNA expression in urothelial carcinomas: Important roles of miR‐10a, miR‐222, miR‐125b, miR‐7 and miR‐452 for tumor stage and metastasis, and frequent homozygous losses of miR‐31 , 2009, International journal of cancer.
[36] G. Lorusso,et al. The tumor microenvironment and its contribution to tumor evolution toward metastasis , 2008, Histochemistry and Cell Biology.
[37] Jun Yao,et al. Distinct epigenetic changes in the stromal cells of breast cancers , 2005, Nature Genetics.
[38] Robert D. Cardiff,et al. Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis , 2005, Cell.
[39] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[40] O. Britanova,et al. Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissue‐specific manner and demonstrates cell‐type‐dependent expression in the developing mouse CNS , 2005, The European journal of neuroscience.
[41] A. Rosenberg,et al. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 down-regulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy , 2008, Cancer biology & therapy.
[42] R. Vyzula,et al. Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.
[43] M. Blagosklonny,et al. Molecular theory of cancer , 2005, Cancer biology & therapy.
[44] Nicholas T. Ingolia,et al. Mammalian microRNAs predominantly act to decrease target mRNA levels , 2010, Nature.
[45] &agr;-Smooth Muscle Actin-Positive Myofibroblasts in Endometrial Stroma Are Not a Reliable Criterion for the Diagnosis of Well Differentiated Endometrioid Adenocarcinoma in Small Tissue Samples , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[46] D. Corcoran,et al. Features of Mammalian microRNA Promoters Emerge from Polymerase II Chromatin Immunoprecipitation Data , 2009, PloS one.
[47] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[48] R. Grosschedl,et al. SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. , 2003, Genes & development.
[49] O. Britanova,et al. Satb2 haploinsufficiency phenocopies 2q32-q33 deletions, whereas loss suggests a fundamental role in the coordination of jaw development. , 2006, American journal of human genetics.
[50] Dennis C. Sgroi,et al. Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.
[51] C. Morrison,et al. Combined Total Genome Loss of Heterozygosity Scan of Breast Cancer Stroma and Epithelium Reveals Multiplicity of Stromal Targets , 2004, Cancer Research.
[52] G. Bratthauer,et al. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. , 2000, Cancer research.